参考文献/References:
[1] LEE R W,NICHOLSON L B,SEN H N,CHAN C C,WEI L,NUSSENBLATT R B,et al.Autoimmune and autoinflammatory mechanisms in uveitis[J].Semin Immunopathol,2014,36(5):581-594.
[2] LI B,YANG L,BAI F,TONG B,LIU X.Indications and effects of biological agents in the treatment of noninfectious uveitis[J].Immunotherapy,2022,14(12):985-994.
[3] GU L,LIN J,WANG Q,LI C,PENG X,FAN Y,et al.Dimethyl itaconate protects against fungal keratitis by activating the Nrf2/HO-1 signaling pathway[J].Immunol Cell Biol,2020,98(3):229-241.
[4] KUO P C,WENG W T,SCOFIELD B A,PARAISO H C,BROWN D A,WANG P Y,et al.Dimethyl itaconate,an itaconate derivative,exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis[J].J Neuroinflammation,2020,17(1):138.
[5] LAMPROPOULOU V,SERGUSHICHEV A,BAMBOUSKOVA M,NAIR S,VINCENT E E,LOGINICHEVA E,et al.Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation[J].Cell Metab,2016,24(1):158-166.
[6] IWASAKI A,MEDZHITOV R.Regulation of adaptive immunity by the innate immune system[J].Science,2010,327(5963):291-295.
[7] JOFFRE O,NOLTE M A,SPORRI R,REIS E SOUSA C.Inflammatory signals in dendritic cell activation and the induction of adaptive immunity[J].Immunol Rev,2009,227(1):234-247.
[8] AGARWAL R K,CASPI R R.Rodent models of experimental autoimmune uveitis[J].Methods Mol Med,2004,102:395-419.
[9] MADDUR M S,MIOSSEC P,KAVERI S V,BAYRY J.Th17 cells:biology,pathogenesis of autoimmune and inflammatory diseases,and therapeutic strategies[J].Am J Pathol,2012,181(1):8-18.
[10] YANG J,SUNDRUD M S,SKEPNER J,YAMAGATA T.Targeting Th17 cells in autoimmune diseases[J].Trends Pharmacol Sci,2014,35(10):493-500.
[11] HAMZAOUI K,BOUALI E,GHORBEL I,KHANFIR M,HOUMAN H,HAMZAOUI A.Expression of Th-17 and RORgammat mRNA in Behcet’s Disease[J].Med Sci Monit,2011,17(4):CR227-234.
[12] CHEN P,DENNISTON A K,HIRANI S,HANNES S,NUSSENBLATT R B.Role of dendritic cell subsets in immunity and their contribution to noninfectious uveitis[J].Surv Ophthalmol,2015,60(3):242-249.
[13] YIN X,CHEN S,EISENBARTH S C.Dendritic Cell Regulation of T Helper Cells[J].Annu Rev Immunol,2021,39:759-790.
[14] RUNTSCH M C,ANGIARI S,HOOFTMAN A,WADHWA R,ZHANG Y,ZHENG Y,et al.Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages[J].Cell Metab,2022,34(3):487-501 e488.
[15] REN J,YU L,LIN J,MA L,GAO D S,SUN N,et al.Dimethyl itaconate inhibits neuroinflammation to alleviate chronic pain in mice[J].Neurochem Int,2022,154:105296.
[16] ZHANG S,JIAO Y,LI C,LIANG X,JIA H,NIE Z,et al.Dimethyl Itaconate Alleviates the Inflammatory Responses of Macrophages in Sepsis[J].Inflammation,2021,44(2):549-557.
[17] LIN J,REN J,ZHU B,DAI Y,GAO D S,XIA S,et al.Dimethyl Itaconate Attenuates CFA-Induced Inflammatory Pain via the NLRP3/ IL-1beta Signaling Pathway[J].Front Pharmacol,2022,13:938979.
[18] NAKKALA J R,YAO Y,ZHAI Z,DUAN Y,ZHANG D,MAO Z,et al.Dimethyl Itaconate-Loaded Nanofibers Rewrite Macrophage Polarization,Reduce Inflammation,and Enhance Repair of Myocardic Infarction[J].Small,2021,17(17):e2006992.
[19] WU B,WAN Y.Molecular control of pathogenic Th17 cells in autoimmune diseases[J].Int Immunopharmacol,2020,80:106187.
[20] GAFFEN S L,JAIN R,GARG A V,CUA D J.The IL-23-IL-17 immune axis:from mechanisms to therapeutic testing[J].Nat Rev Immunol,2014,14(9):585-600.
[21] YASUDA K,TAKEUCHI Y,HIROTA K.The pathogenicity of Th17 cells in autoimmune diseases[J].Semin Immunopathol,2019,41(3):283-297.
[22] SONDEREGGER I,IEZZI G,MAIER R,SCHMITZ N,KURRER M,KOPF M.GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival[J].J Exp Med,2008,205(10):2281-2294.